Yongxia R. Zhu

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Okra Flower Polysaccharides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis by Modulating ABC Transporters Via the Gut Microbiota.

Okra Flower Polysaccharides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis by Modulating ABC Transporters Via the Gut Microbiota.

Journal: Journal of agricultural and food chemistry

Published: March 18, 2026

Melatonin Influences Bmi1+ Intestinal Stem Cell Fate Through Metabolic Regulation After Irradiation.

Melatonin Influences Bmi1+ Intestinal Stem Cell Fate Through Metabolic Regulation After Irradiation.

Journal: Journal of pineal research

Published: September 05, 2025

Design, synthesis, and biological evaluation of novel PI3Kδ/HDAC6 dual inhibitors for the treatment of non-Hodgkin's lymphoma.

Design, synthesis, and biological evaluation of novel PI3Kδ/HDAC6 dual inhibitors for the treatment of non-Hodgkin's lymphoma.

Journal: European journal of medicinal chemistry

Published: April 22, 2025

Exploring the potential of Huangqin Tang in breast cancer treatment using network pharmacological analysis and experimental verification.

Exploring the potential of Huangqin Tang in breast cancer treatment using network pharmacological analysis and experimental verification.

Journal: BMC complementary medicine and therapies

Published: March 18, 2024

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH.

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH.

Journal: Life sciences

Published: October 15, 2023

Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.

Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: August 10, 2023

A patent review of EZH2 inhibitors from 2017 and beyond.

A patent review of EZH2 inhibitors from 2017 and beyond.

Journal: Expert opinion on therapeutic patents

Published: April 25, 2023

Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer.

Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer.

Journal: Journal of medicinal chemistry

Published: January 24, 2023

Editorial: Epigenetic regulation and therapy resistance in cancer.

Editorial: Epigenetic regulation and therapy resistance in cancer.

Journal: Frontiers in pharmacology

Published: December 08, 2022

Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.

Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.

Journal: Biochemical pharmacology

Published: November 08, 2022

Analysis of synthetic electron cyclotron emission from the high field side of HL-2M tokamak plasmas.

Analysis of synthetic electron cyclotron emission from the high field side of HL-2M tokamak plasmas.

Journal: The Review of scientific instruments

Published: September 01, 2022

Design, synthesis and biological evaluation of a new class of 7H-pyrrolo[2,3-d]pyrimidine derivatives as Mps1 inhibitors for the treatment of breast cancer.

Design, synthesis and biological evaluation of a new class of 7H-pyrrolo[2,3-d]pyrimidine derivatives as Mps1 inhibitors for the treatment of breast cancer.

Journal: European journal of medicinal chemistry

Published: August 08, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026